Insights Widest with the analysis, Proactive gives perspectives that others don't.

Cellmid Limited - Cellmid takes on aging with both consumer products and pharmaceuticals Cellmid takes on aging with both consumer products and pharmaceuticals

Cellmid Ltd (ASX:CDY) is a life sciences company focused on developing solutions for conditions...

on 19/12/19
Deep dive

Medlab Clinical inks UK and US distribution deals for nutraceuticals

Medlab Clinical Ltd revealed in December that it had raised $5mln in an oversubscribed share...

on 17/12/19
Deep dive

Opyl to use artificial intelligence to digitally transform Australia’s...

Combining new technologies and healthcare expertise, the company’s key offerings include...

on 9/12/19
Deep dive

Zoetic International makes rapid progress with new CBD business

Zoetic sells CBD chew pouches under the Chill brand in the US and is launching the brand in the...

on 26/11/19
Deep dive

Cellmid directors show faith in company by participating in share placement

Through wholly-owned subsidiaries such as Lyramid, Kinera and Advangen, the company develops and...

on 22/11/19


Bulls, Bears & Brokers: Alto Capital’s Tony Locantro on Nyrada IPO and small...

Alto Capital investment manager and stock market commentator Tony Locantro updates Proactive on this week's listing of Nyrada Inc (ASX:NYR), a spin-off of Noxopharm Ltd’s (ASX:NOX). He discusses the reasons for the spin-off, including some of the recent and expected trading patterns. Locantro...

1 week, 1 day ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.